Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale Director sold 60,000 shares at $25.03 ($1,501,752)
  2. 4 Open-market sale EXEC VP, CFO AND CBO sold 30,000 shares at $24.88 ($746,334)
  3. 4 Option exercise CEO acquired 6,500 shares (option exercise)
  4. 4 Option exercise EXEC VP, CFO AND CBO acquired 12,000 shares (option exercise)
  5. 4 Open-market sale Director sold 44,117 shares at $23.41 ($1,032,911)
  6. 4 Open-market sale CEO sold 15,000 shares at $23.45 ($351,807)
  7. 4 Open-market sale Director sold 37,692 shares at $23.00 ($867,033)
  8. 4 Open-market sale CEO sold 15,000 shares at $23.24 ($348,638)
  9. 4 Open-market sale Director sold 10,000 shares at $21.63 ($216,256)
  10. 4 Open-market sale EXEC VP, CFO AND CBO sold 30,000 shares at $27.87 ($836,121)
  11. 4 Open-market sale EVP, DEVELOPMENT AND CMO sold 35,965 shares at $25.01 ($899,312)
  12. 4 Open-market sale Director sold 60,000 shares at $22.92 ($1,375,470)
  13. 4 Open-market sale Director sold 66,356 shares at $22.90 ($1,519,672)
  14. 4 Open-market sale Director sold 46,153 shares at $22.80 ($1,052,145)
  15. 4 Open-market sale Director sold 40,000 shares at $20.28 ($811,100)
  16. 4 Open-market sale Director sold 15,000 shares at an average $20.68 ($310,211)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale CEO sold 52,771 shares at $20.14 ($1,063,061)
  20. 4 Open-market sale EXEC VP, CFO AND CBO sold 60,000 shares at $20.15 ($1,209,180)

Page 23 of 35 · 686 filings